These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5385462)

  • 1. [Therapy of schizophrenia with neuroleptics from the pharmacologic viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(47):1690-3. PubMed ID: 5385462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
    Stille G
    Schweiz Med Wochenschr; 1969 Nov; 99(46):1645-52 contd. PubMed ID: 4391348
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine and schizophrenia.
    Meltzer HY; Goode DJ; Fang VS; Schyve P; Young M
    Lancet; 1976 Nov; 2(7995):1142. PubMed ID: 62982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic pathomorphology during the terminal stages of schizophrenia].
    Vartanian FE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):250-7. PubMed ID: 5661308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental catatonia and psychopharmacology].
    Baruk H
    Therapie; 1972; 27(1):119-31. PubMed ID: 4622806
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic action of neuroleptics and their effects in the psychology of schizophrenia].
    López-Ibor Aliño JJ
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(3):171-80. PubMed ID: 797239
    [No Abstract]   [Full Text] [Related]  

  • 8. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of TPS-23 and thioridazine in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):520-7. PubMed ID: 4953851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lyogen therapy of outcome states in schizophrenia with catatonic symptoms].
    Gorskiĭ GD; Rybakov VL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1575-8. PubMed ID: 5490155
    [No Abstract]   [Full Text] [Related]  

  • 11. [What should the general practitioner know about the treatment of chronic schizophrenia with long-acting neuroleptics?].
    Beier R; Friemert K; Vehreschild T
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1206-7. PubMed ID: 4791840
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic properties of loxapine succinate.
    Gershon S; Hekimian LJ; Burdock EI; Kim SS
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical psychopharmacology in its 20th year. Late, unanticipated effects of neuroleptics may limit their use in psychiatry.
    Crane GE
    Science; 1973 Jul; 181(4095):124-8. PubMed ID: 4711733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptics, schizophrenia and institutional therapy].
    Aldama de Llano JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1975; 3(3):181-8. PubMed ID: 1163334
    [No Abstract]   [Full Text] [Related]  

  • 15. Suggestions for a rational aproach to the chemotherapy of schizophrenia.
    Zavodnick S
    Dis Nerv Syst; 1976 Dec; 37(12):671-5. PubMed ID: 1001166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of schizophrenic psychoses using low-potency neuroleptics].
    Kemperdick KT; Nieling C; Steinig A
    Med Klin; 1967 Sep; 62(39):1512-5. PubMed ID: 5596490
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of depot neuroleptics for the longterm treatment of schizophrenic patients (author's transl)].
    Woggon B; Angst J
    Schweiz Rundsch Med Prax; 1977 Apr; 66(14):421-7. PubMed ID: 866293
    [No Abstract]   [Full Text] [Related]  

  • 19. [Presumed relapse of psychosis during long-term treatment with neuroleptics].
    Weiser G; Dafalias C; Tahedl A
    Wien Med Wochenschr; 1976 Aug; 126(32-35):484-9. PubMed ID: 826025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions].
    Vetulani J
    Postepy Hig Med Dosw; 1973; 27(6):725-80. PubMed ID: 4589208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.